as on November 14, 2025 at 2:29 am IST
Day's Low
Day's High
2.20%
Downside
1.84%
Upside
52 Week's Low
52 Week's High
33.24%
Downside
6.69%
Upside
Check Biogen Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$23.4B
EPS (TTM)
15.0793
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.19%
PE Ratio (TTM)
14.55
Industry PE ratio
19.200384615384614
PEG Ratio
6.2424
EBITDA
3.4B
Revenue (TTM)
10.1B
Profit Margin
15.98%
Return On Equity TTM
9.31%
Track how Biogen Inc. P/E has moved over time to understand its valuation trends.
Biogen Inc. in the last 5 years
Lowest (7.86x)
December 31, 2020
Today (14.55x)
November 13, 2025
Industry (19.20x)
November 13, 2025
Highest (18.33x)
June 30, 2023
Today’s Price to Earnings Ratio: 14.55x
Compare market cap, revenue, PE, and other key metrics of Biogen Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $23.4B | -35.04% | 14.55 | 15.98% | |
| BUY | $884.8B | 614.83% | 48.46 | 30.99% | |
| BUY | $398.0B | 135.49% | 169.3 | 4.00% | |
| BUY | $467.0B | 29.68% | 18.73 | 27.26% | |
| BUY | $225.7B | 12.78% | 12.03 | 29.63% |
The Biogen Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Biogen Inc. investment value today
Current value as on today
₹1,04,559
Returns
₹4,559
(+4.56%)
Returns from Biogen Inc. Stock
Dollar Returns*
₹5,138 (+5.14%)
Based on 42 analysts
71.43%
Buy
28.57%
Hold
0.00%
Sell
Based on 42 analysts, 71.43% of analysts recommend a 'BUY' rating for Biogen Inc.. Average target price of $176.72
Get share price movements and forecasts by analysts on Biogen Inc..
What analysts predicted
6.73%UPSIDE
Target Price
$176.72
Current Price
$164.83
Analyzed by
42 Analysts
Target
$176.72
Biogen Inc. target price $176.72, a slight upside of 6.73% compared to current price of $164.83. According to 42 analysts rating.
Search interest for Biogen Inc. Stock has decreased by -46% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 06 November
Thu, 11:08 AM
-Biogen's Q3 results beat expectations with $2.53 billion revenue and $4.81 EPS, driven by new product performance.
Thu, 06:23 PM
-Stifel upgrades Biogen to Buy from Hold, raising price target to $202, citing favorable risk/reward and clinical catalysts.
Thu, 09:28 PM
-New options for Biogen available; put and call contracts identified with potential attractive returns.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, BIIB stock has moved up by 11.6%
Against Peers
![]()
In the last 3 years, Eli Lilly And Company has given 55.3% return, outperforming this stock by 99.5%
Against Peers
![]()
In the last 1 year, Abbvie Inc has given 36.9% return, outperforming this stock by 39.5%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 2.64B → 2.45B (in $), with an average decrease of 7.2% per quarter
Profit Down
![]()
Netprofit is down for the last 2 quarters, 634.8M → 466.5M (in $), with an average decrease of 26.5% per quarter
| Organisation | Biogen Inc. |
| Headquarters | 225 Binney Street, Cambridge, MA, United States, 02142 |
| Industry | Health Technology |
| CEO | Mr. Christopher A. Viehbacher |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Robin C. Kramer | Executive VP & CFO |
Mr. Sean Godbout | Chief Accounting Officer & Global Corporate Controller |
Mr. Guy Hadari | Chief Information Officer |
Mr. Adam Keeney Ph.D. | Executive VP & Head of Corporate Development |
Dr. Ginger Gregory Ph.D. | Executive VP & Chief Human Resources Officer |
Mr. Christopher A. Viehbacher | President, CEO & Director |
Ms. Nicole Murphy | Executive VP and Head of Pharmaceutical Operations & Technology |
Dr. Priya Singhal M.D., M.P.H. | Executive VP & Head of Development |
Ms. Susan H. Alexander Esq. | Executive VP & Chief Legal Officer |
Mr. Tim Power M.B.A., Ph.D. | Head of Investor Relations |
Biogen Inc. share price today is $164.83 as on at the close of the market. Biogen Inc. share today touched a day high of $167.87 and a low of $161.2.
Biogen Inc. share touched a 52 week high of $175.86 on and a 52 week low of $110.04 on . Biogen Inc. stock price today i.e. is closed at $164.83,which is 6.27% down from its 52 week high and 49.80% up from its 52 week low.
Biogen Inc. market capitalisation is $0.02T as on .
Indian investors can start investing in Biogen Inc. (BIIB) shares with as little as ₹88.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.52 in Biogen Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Biogen Inc. share’s latest price of $164.83 as on November 14, 2025 at 2:29 am IST, you will get 0.0607 shares of Biogen Inc.. Learn more about
fractional shares .
Biogen Inc. stock has given -35.04% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?